Document is current
Any future updates will be listed below
-
Authors
Imanishi, Yasuo
Taniuchi, Satsuki
Kodama, Sho
Yoshida, Hisako
Ito, Tetsuo
Kawai, Ryota
Okubo, Naoki
Shintani, Ayumi
-
Funding
Funding for this research was provided by:
Daiichi Sankyo Co., Ltd.
- License Information
-
More Information
Article History
Received: 26 April 2024
Accepted: 10 September 2024
First Online: 14 October 2024
Declarations
:
: Employment: S. Kodama, T. Ito, and N. Okubo (Daiichi Sankyo Co., Ltd.), Consultancies: S. Taniuchi, H. Yoshida, and R. Kawai (Chugai Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd., and Kyowa Kirin Co., Ltd.); H. Yoshida (Kyowa Kirin Co., Ltd.); A. Shintani and/or her institution (Chugai Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd., Kyowa Kirin Co., Ltd., Takeda Pharmaceutical Co., Ltd., Shionogi & Co., Ltd., and Mallinckrodt Pharma K.K.), Honoraria: Y. Imanishi (Daiichi Sankyo Co., Ltd., Teijin Healthcare Ltd., Kyowa Kirin Co., Ltd., and Asahi Kasei Pharma Corporation); A. Shintani (AbbVie G.K., Asahi Kasei Pharma Corporation, AstraZeneca K.K., Astellas Pharma Inc., Bayer Yakuhin, Ltd., Bristol-Myers Squibb K.K., Chugai Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd., Eisai Co., Ltd., Janssen Pharmaceutical K.K., Kissei Pharmaceutical Co., Ltd., Kyowa Kirin Co., Ltd., Mallinckrodt Pharma K.K., Merck Biopharma Co., Ltd., Maruho Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Nipro Corporation, Novo Nordisk Pharma Ltd., Nippon Shinyaku Co., Ltd., Ono Pharmaceutical Co., Ltd., Pfizer Japan Inc., Takeda Pharmaceutical Co., Ltd., Taisho Pharmaceutical Co., Ltd., Torii Pharmaceutical Co., Ltd., Sanofi K.K., Nippon Kayaku Co., Ltd., JCR Pharmaceuticals Co., Ltd., and MSD K.K.), Stock ownership or options: None reported, Grants received: Y. Imanishi, S. Taniuchi, H. Yoshida, R. Kawai, A. Shintani (Daiichi Sankyo Co., Ltd.); H. Yoshida (Organization for Clinical Medicine Promotion).
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee at which the studies were conducted (Medical Corporation TOUKEIKAI Kitamachi Clinic Ethical Review Board, approved 24 May 2023) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was not obtained for this study because patient data were anonymized.
